SCHEMBL17899605

SCHEMBL17899605

Cc1ccc(S(=O)(=O)N2CC=C(C(=O)NO)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
MAPT P10636 1/20 0.55
HPGD P15428 1/20 0.55
RECQL P46063 1/20 0.55
PKM P14618 5/20 0.52
TDP1 Q9NUW8 2/20 0.50
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19472038 0.89 LMNA (0.55) LMNAMAPTHPGDRECQLPKM
SCHEMBL15818959 0.86 LMNA (0.72) LMNAMAPTHPGDRECQLPKM
SCHEMBL17899608 0.86 PKM (0.50) LMNAMAPTPKMTDP1HDAC3
SCHEMBL17899618 0.86 HDAC1 (0.46) MAPTPKMHDAC3HDAC4HDAC1
SCHEMBL17899611 0.85 LMNA (0.49) LMNAHDAC3HDAC1HDAC11HDAC8
SCHEMBL17899600 0.85 KMT2A (0.56) MAPTPKMHDAC1MEN1KMT2A
SCHEMBL17899616 0.85 HDAC6 (0.47) LMNAMAPTHPGDRECQLTDP1
SCHEMBL17899621 0.85 AKR1C3 (0.47) LMNAMAPTHPGDRECQLPKM
SCHEMBL17899617 0.84 KMT2A (0.58) LMNAMAPTPKMMEN1KMT2A
SCHEMBL17899620 0.84 HDAC1 (0.50) LMNAMAPTHPGDRECQLPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266489-B2 Pyrrolic amide compound and preparation method and application thereof HITGEN LTD (CN) 2019-04-23 US disclosed
US-10266489-B2 Pyrrolic amide compound and preparation method and application thereof HITGEN LTD (CN) 2019-04-23 US disclosed
EP-3241823-B1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF HITGEN LTD (CN) 2019-04-17 EP disclosed
EP-3241823-B1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF HITGEN LTD (CN) 2019-04-17 EP disclosed
EP-3241823-A1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Hitgen Ltd. (CN) 2017-11-08 EP disclosed
EP-3241823-A1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF Hitgen Ltd. (CN) 2017-11-08 EP disclosed
US-20170298016-A1 PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF HITGEN INC. (CN) 2017-10-19 US disclosed
US-20170298016-A1 PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF HITGEN INC. (CN) 2017-10-19 US disclosed
US-20170298016-A1 PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF HITGEN INC. (CN) 2017-10-19 US disclosed
WO-2016107544-A1 INTERMEDIATE COMPOUND FOR PREPARING PYRROLE AMIDE COMPOUND AND PREPARATION METHOD AND USE THEREOF 成都先导药物开发有限公司 2016-07-07 WO disclosed
WO-2016107227-A1 PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 成都先导药物开发有限公司 2016-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298016-A1 PYRROLIC AMIDE COMPOUND AND PREPARATION METHOD AND APPLICATION THEREOF HDAC1, HDAC3, HDAC11 LMNA 1827/4885MAPT 3879/4885HPGD 520/4885
US-10266489-B2 Pyrrolic amide compound and preparation method and application thereof HDAC1, HDAC3, HDAC11 LMNA 1827/4885MAPT 3879/4885HPGD 520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.